ARVN
ARVINAS, INC.
NASDAQ · Healthcare · Biotechnology · US
$7.26
+4.16%Research · Sep 3, 2026
ARVN: FY25 Deep Dive
Arvinas FY25 at $263M. NI $-81M; EPS $-1.28.
NASDAQ · Healthcare · Biotechnology · US
Research · Sep 3, 2026
Arvinas FY25 at $263M. NI $-81M; EPS $-1.28.